Farmak, the leader of the domestic pharmaceutical industry, presented Avouge®, a range of products for contouring plastics and correction of age-related skin changes, at the 13th International Exhibition of Perfumery and Cosmetics InterCharm2014, held in September at the International Exhibition Center in Kyiv.
Farmak’s stand featured biogels of Avouge® line – Avouge® and Avouge® Plus, and hyaluronic acid-based products: Hyaral® and Hyaral® Plus used in ophthalmic surgery.
Avouge® cosmetic product is a drug for use in aesthetic medicine and cosmetology. Its production involves a unique technology of hyaluronic acid stabilization. Due to this, Avouge® biogels have a lasting and express aesthetic effect and promote deep skin hydration.
Due to the high concentration of hyaluronic acid and the use of LG Life Science's proprietary HESH-technology, Avouge® biogels are long retained by the dermis, fixed at the injection site, do not migrate into other tissues, and contribute to maximum prolongation of effects of contouring plastics.
Avouge® biogels are comparable with the most popular cosmetological brands in terms of their qualitative characteristics and lasting effects, while the reasonable prices make contouring plastics much more affordable for a wider range of patients.
The participation in InterCharm2014 is merely the beginning of Farmak's marketing activities towards cooperation with cosmetologists, and a kick-start for successful promotion of the new product line.
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]
The Memorandum is aimed at developing the mutual cooperation in the implementation of the state programs of the Republic of Uzbekistan for the further development of the national pharmaceutical industry. “We know the Uzbek market well and we are committed to develop cooperation. Farmak has been present in Uzbekistan since 2004. The residents of this [&hellip...